No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
1 | Adrenergic signaling in cardiomyocytes 1 gene, 1 drug (DrugBank) and 13 diseases shown |
1件: ADRB2 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
2 | Alanine, aspartate and glutamate metabolism 4 genes, 1 drug (DrugBank) and 14 diseases shown |
4件: ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
3 | Alcoholism 5 genes, 1 drug (DrugBank) and 7 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
4 | Aldosterone synthesis and secretion 3 genes, 1 drug (DrugBank) and 14 diseases shown |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
5 | Alzheimer disease 5 genes, 1 drug (DrugBank) and 7 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
6 | Amphetamine addiction 9 genes, 1 drug (DrugBank) and 7 diseases shown |
9件: GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
7 | Amyotrophic lateral sclerosis (ALS) 7 genes, 1 drug (DrugBank) and 7 diseases shown |
7件: GRIA1, GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
8 | Arachidonic acid metabolism 2 genes, 2 drugs (DrugBank) and 17 diseases shown |
2件: PTGS1, PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
9 | beta-Alanine metabolism 3 genes, 1 drug (DrugBank) and 14 diseases shown |
3件: ABAT, GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
10 | Butanoate metabolism 4 genes, 1 drug (DrugBank) and 14 diseases shown |
4件: ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
11 | C-type lectin receptor signaling pathway 1 gene, 2 drugs (DrugBank) and 17 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
12 | Calcium signaling pathway 9 genes, 4 drugs (DrugBank) and 26 diseases shown |
1件: ADRB2 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
4件: GRIN1, GRIN2A, GRIN2C, GRIN2D |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
1件: TNNC2 |
D11363 |
Reldesemtiv |
2件: 2, 3 |
13 | cAMP signaling pathway 10 genes, 2 drugs (DrugBank) and 18 diseases shown |
1件: ADRB2 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
9件: GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
14 | cGMP-PKG signaling pathway 1 gene, 1 drug (DrugBank) and 13 diseases shown |
1件: ADRB2 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
15 | Chemical carcinogenesis 1 gene, 2 drugs (DrugBank) and 17 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
16 | Cholinergic synapse 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: ACHE |
D00487 |
Pyridostigmine |
4件: 3, 6, 11, 256 |
17 | Circadian entrainment 12 genes, 2 drugs (DrugBank) and 17 diseases shown |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
9件: GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
18 | Cocaine addiction 6 genes, 1 drug (DrugBank) and 7 diseases shown |
6件: GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
19 | Cortisol synthesis and secretion 4 genes, 3 drugs (DrugBank) and 18 diseases shown |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
1件: KCNA4 |
D10228 |
Amifampridine |
3件: 3, 11, 12 |
D04127 |
Dalfampridine |
3件: 3, 4, 13 |
20 | Cushing syndrome 4 genes, 3 drugs (DrugBank) and 18 diseases shown |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
1件: KCNA4 |
D10228 |
Amifampridine |
3件: 3, 11, 12 |
D04127 |
Dalfampridine |
3件: 3, 4, 13 |
21 | Cytokine-cytokine receptor interaction 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: GHR |
D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
22 | Dopaminergic synapse 6 genes, 1 drug (DrugBank) and 7 diseases shown |
6件: GRIA1, GRIA2, GRIA3, GRIA4, GRIN2A, GRIN2B |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
23 | Drug metabolism - other enzymes 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: RRM2 |
D00341 |
Hydroxyurea |
8件: 3, 13, 19, 20, 65, 85, 86, 284 |
24 | GABAergic synapse 19 genes, 2 drugs (DrugBank) and 22 diseases shown |
3件: ABAT, GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
25 | Glutamatergic synapse 14 genes, 1 drug (DrugBank) and 7 diseases shown |
14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
26 | Glutathione metabolism 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: RRM2 |
D00341 |
Hydroxyurea |
8件: 3, 13, 19, 20, 65, 85, 86, 284 |
27 | Glycerophospholipid metabolism 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: ACHE |
D00487 |
Pyridostigmine |
4件: 3, 6, 11, 256 |
28 | GnRH secretion 3 genes, 1 drug (DrugBank) and 14 diseases shown |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
29 | GnRH signaling pathway 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: GNRHR |
D00989 |
Leuprolide |
5件: 1, 2, 3, 51, 76 |
30 | Growth hormone synthesis, secretion and action 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: GHR |
D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
31 | Human cytomegalovirus infection 1 gene, 2 drugs (DrugBank) and 17 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
32 | Human papillomavirus infection 1 gene, 2 drugs (DrugBank) and 17 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
33 | Huntington disease 2 genes, 1 drug (DrugBank) and 7 diseases shown |
2件: GRIN1, GRIN2B |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
34 | IL-17 signaling pathway 1 gene, 2 drugs (DrugBank) and 17 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
35 | JAK-STAT signaling pathway 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: GHR |
D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
36 | Kaposi sarcoma-associated herpesvirus infection 1 gene, 2 drugs (DrugBank) and 17 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
37 | Leishmaniasis 1 gene, 2 drugs (DrugBank) and 17 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
38 | Long-term depression 3 genes, 1 drug (DrugBank) and 7 diseases shown |
3件: GRIA1, GRIA2, GRIA3 |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
39 | Long-term potentiation 7 genes, 1 drug (DrugBank) and 7 diseases shown |
7件: GRIA1, GRIA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
40 | MAPK signaling pathway 3 genes, 1 drug (DrugBank) and 14 diseases shown |
3件: CACNA1G, CACNA1H, CACNA1I |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
41 | Metabolic pathways 7 genes, 4 drugs (DrugBank) and 30 diseases shown |
4件: ABAT, ALDH5A1, GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
2件: PTGS1, PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
1件: RRM2 |
D00341 |
Hydroxyurea |
8件: 3, 13, 19, 20, 65, 85, 86, 284 |
42 | MicroRNAs in cancer 1 gene, 2 drugs (DrugBank) and 17 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
43 | Morphine addiction 16 genes, 1 drug (DrugBank) and 10 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
44 | Neuroactive ligand-receptor interaction 33 genes, 5 drugs (DrugBank) and 38 diseases shown |
1件: ADRB2 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
1件: GHR |
D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
1件: GNRHR |
D00989 |
Leuprolide |
5件: 1, 2, 3, 51, 76 |
14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
45 | NF-kappa B signaling pathway 1 gene, 2 drugs (DrugBank) and 17 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
46 | Nicotine addiction 25 genes, 2 drugs (DrugBank) and 14 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
9件: GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
47 | Oocyte meiosis 1 gene, 1 drug (DrugBank) and 7 diseases shown |
1件: AR |
D00075 |
Testosterone |
7件: 1, 2, 3, 13, 78, 113, 265 |
D00957 |
D00958 |
D00959 |
D06085 |
D06087 |
48 | Ovarian steroidogenesis 1 gene, 2 drugs (DrugBank) and 17 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
49 | Oxytocin signaling pathway 1 gene, 2 drugs (DrugBank) and 17 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
50 | p53 signaling pathway 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: RRM2 |
D00341 |
Hydroxyurea |
8件: 3, 13, 19, 20, 65, 85, 86, 284 |
51 | Pathways in cancer 2 genes, 3 drugs (DrugBank) and 21 diseases shown |
1件: AR |
D00075 |
Testosterone |
7件: 1, 2, 3, 13, 78, 113, 265 |
D00957 |
D00958 |
D00959 |
D06085 |
D06087 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
52 | PI3K-Akt signaling pathway 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: GHR |
D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
53 | Platelet activation 1 gene, 1 drug (DrugBank) and 13 diseases shown |
1件: PTGS1 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
54 | Propanoate metabolism 1 gene, 1 drug (DrugBank) and 14 diseases shown |
1件: ABAT |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
55 | Prostate cancer 1 gene, 1 drug (DrugBank) and 7 diseases shown |
1件: AR |
D00075 |
Testosterone |
7件: 1, 2, 3, 13, 78, 113, 265 |
D00957 |
D00958 |
D00959 |
D06085 |
D06087 |
56 | Purine metabolism 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: RRM2 |
D00341 |
Hydroxyurea |
8件: 3, 13, 19, 20, 65, 85, 86, 284 |
57 | Pyrimidine metabolism 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: RRM2 |
D00341 |
Hydroxyurea |
8件: 3, 13, 19, 20, 65, 85, 86, 284 |
58 | Rap1 signaling pathway 3 genes, 1 drug (DrugBank) and 7 diseases shown |
3件: GRIN1, GRIN2A, GRIN2B |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
59 | Ras signaling pathway 3 genes, 1 drug (DrugBank) and 7 diseases shown |
3件: GRIN1, GRIN2A, GRIN2B |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
60 | Regulation of lipolysis in adipocytes 3 genes, 3 drugs (DrugBank) and 23 diseases shown |
1件: ADRB2 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
2件: PTGS1, PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
61 | Renin secretion 1 gene, 1 drug (DrugBank) and 13 diseases shown |
1件: ADRB2 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
62 | Retrograde endocannabinoid signaling 21 genes, 4 drugs (DrugBank) and 23 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
4件: GRIA1, GRIA2, GRIA3, GRIA4 |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
63 | RNA transport 1 gene, 2 drugs (DrugBank) and 1 disease shown |
1件: SMN2 |
D10881 |
Nusinersen |
1件: 3 |
D11406 |
Risdiplam |
1件: 3 |
64 | Salivary secretion 1 gene, 1 drug (DrugBank) and 13 diseases shown |
1件: ADRB2 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
65 | Serotonergic synapse 6 genes, 5 drugs (DrugBank) and 22 diseases shown |
3件: GABRB1, GABRB2, GABRB3 |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
1件: KCND2 |
D10228 |
Amifampridine |
3件: 3, 11, 12 |
D04127 |
Dalfampridine |
3件: 3, 4, 13 |
2件: PTGS1, PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
66 | Small cell lung cancer 1 gene, 2 drugs (DrugBank) and 17 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
67 | Systemic lupus erythematosus 2 genes, 1 drug (DrugBank) and 7 diseases shown |
2件: GRIN2A, GRIN2B |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
68 | Taste transduction 6 genes, 1 drug (DrugBank) and 10 diseases shown |
6件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
D00696 |
D05028 |
69 | Taurine and hypotaurine metabolism 2 genes, 1 drug (DrugBank) and 14 diseases shown |
2件: GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
70 | TNF signaling pathway 1 gene, 2 drugs (DrugBank) and 17 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
71 | Transcriptional misregulation in cancer 1 gene, 1 drug (DrugBank) and 7 diseases shown |
1件: GRIA3 |
D00775 |
Riluzole |
7件: 2, 3, 5, 8, 13, 17, 206 |
72 | Type I diabetes mellitus 2 genes, 1 drug (DrugBank) and 14 diseases shown |
2件: GAD1, GAD2 |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
73 | Type II diabetes mellitus 1 gene, 1 drug (DrugBank) and 14 diseases shown |
1件: CACNA1G |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
74 | Valine, leucine and isoleucine degradation 1 gene, 1 drug (DrugBank) and 14 diseases shown |
1件: ABAT |
D00399 |
Valproic Acid |
14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
75 | VEGF signaling pathway 1 gene, 2 drugs (DrugBank) and 17 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |